Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Archer

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Hormone Molecular Biology and Clinical Investigation|January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label studyCéline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Menopause (New York, N.Y.)|October 26, 2018
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
Contraception|October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trialsMelissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Obstetrics and Gynecology|March 10, 2015
Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user inputJill L Schwartz, Debra H Weiner, Jaim Jou Lai, et al.
The Journal of Sexual Medicine|November 25, 2015
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal AtrophyFernand Labrie, Leonard Derogatis, David F Archer, et al.
AIDS Research and Human Retroviruses|July 27, 2013
Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failureChristine K Mauck, Jaim Jou Lai, Debra H Weiner, et al.
Contraception|May 17, 2020
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetateMelissa J Chen, Mitchell D Creinin, David K Turok, et al.
Expert Review of Clinical Pharmacology|March 21, 2022
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopauseCéline Gérard, Jean-François Arnal, Maud Jost, et al.
Menopause (New York, N.Y.)|June 6, 2018
The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel reviewJames A Simon, Irwin Goldstein, Noel N Kim, et al.
Obstetrics and Gynecology|September 4, 2007
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart, Michael J Rosenberg, H Trent MacKay, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Hormone Molecular Biology and Clinical Investigation|January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label studyCéline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Menopause (New York, N.Y.)|October 26, 2018
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
Contraception|October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trialsMelissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Obstetrics and Gynecology|March 10, 2015
Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user inputJill L Schwartz, Debra H Weiner, Jaim Jou Lai, et al.
The Journal of Sexual Medicine|November 25, 2015
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal AtrophyFernand Labrie, Leonard Derogatis, David F Archer, et al.
AIDS Research and Human Retroviruses|July 27, 2013
Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failureChristine K Mauck, Jaim Jou Lai, Debra H Weiner, et al.
Contraception|May 17, 2020
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetateMelissa J Chen, Mitchell D Creinin, David K Turok, et al.
Expert Review of Clinical Pharmacology|March 21, 2022
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopauseCéline Gérard, Jean-François Arnal, Maud Jost, et al.
Menopause (New York, N.Y.)|June 6, 2018
The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel reviewJames A Simon, Irwin Goldstein, Noel N Kim, et al.
Obstetrics and Gynecology|September 4, 2007
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart, Michael J Rosenberg, H Trent MacKay, et al.
Pageof 18